TEMTempus AI, Inc.

$68.46

$42.3752 weeks$103.25

Price

$68.46+17%1Y

1M+48%1Y+17%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Average

5/10

Value47

Quality39

Momentum48

Growth78

Strongest Growth, weakest Quality · ranked vs Healthcare peers. The five questions below judge the company on its own terms.

What they do

Tempus is a technology company focused on healthcare that straddles two converging worlds. We strive to combine deep healthcare expertise, providing next-generation diagnostics across multiple disease areas, with leading technology capabilities, harnessing the power of data and analytics to help personalize medicine. Unlike traditional diagnostic labs, we can incorporate unique patient information, such as clinical, molecular, and imaging data, with the goal of making our tests more intelligent and our results more insightful.

In the company’s own words · 10-K filed Feb 24, 2026 · SEC EDGAR

P/E (TTM)-

Market Cap$9.13B

1Y Return+17%

5Y Return-

Business segments

Q1 2026 · $348.0M

The company’s own SEC segment disclosure.

Clinical Order$239.3M69%
Insights Product$71.3M20%
Genomics Product$21.8M6%
Trials Product$9.9M3%
Next Product$5.7M2%

Tempus AI, Inc. (TEM) reported revenue of $382M in Q2 2026 (quarter ended June 30, 2026), up 22% from the same quarter a year earlier. That came with net income of $5.6M (1.5% of revenue). For the full year FY2025, revenue was $1.27B (+83% year on year) and net income −$245M. Its largest product in 2026-Q1 was Clinical Order at $239M, 69% of the disclosed total, just ahead of Insights Product at 20%.

Raw charts

8 series · TTM

As reported to the SEC, without any scoring.

Health Information Services

Ranks #12 of 14 by Smart Score

Compare peers

BTSG+3.1%

BrightSpring Health Services, Inc.

Waystar Holding Corp.